Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Evaluating the implementation and impact of a pharmacy technician-supported medicines administration service designed to reduce omitted doses in hospitals: a qualitative study.

Seston EM, Ashcroft DM, Lamerton E, Harper L, Keers RN.

BMC Health Serv Res. 2019 May 22;19(1):325. doi: 10.1186/s12913-019-4146-6.

2.

Reducing acute kidney injury incidence and progression in a large teaching hospital.

Sykes L, Sinha S, Hegarty J, Flanagan E, Doyle L, Hoolickin C, Edwards L, Ferris P, Lamerton E, Poulikakos D, Green D, Nipah R.

BMJ Open Qual. 2018 Nov 26;7(4):e000308. doi: 10.1136/bmjoq-2017-000308. eCollection 2018.

3.

Complications and outcomes of trimethoprim-sulphamethoxazole as chemoprophylaxis for pneumocystis pneumonia in renal transplant recipients.

Mitsides N, Greenan K, Green D, Middleton R, Lamerton E, Allen J, Redshaw J, Chadwick PR, Subudhi CP, Wood G.

Nephrology (Carlton). 2014 Mar;19(3):157-63. doi: 10.1111/nep.12201.

PMID:
24387294
4.

Dapsone-induced methemoglobinemia in renal transplant recipients: more prevalent than previously thought.

Mitsides N, Green D, Middleton R, New D, Lamerton E, Allen J, Redshaw J, Chadwick PR, Subudhi CP, Wood G.

Transpl Infect Dis. 2014 Feb;16(1):37-43. doi: 10.1111/tid.12161. Epub 2013 Nov 12.

PMID:
24215452
5.

Accelerated total dose infusion of low molecular weight iron dextran is safe and efficacious in chronic kidney disease patients.

Sinha S, Chiu D, Peebles G, Swoboda P, Kolakkat S, Lamerton E, Fenwick S, Bhandari S, Kalra PA.

QJM. 2011 Mar;104(3):221-30. doi: 10.1093/qjmed/hcq180. Epub 2010 Oct 18.

PMID:
20956457
6.

The safety of accelerated infusion versus standard rate infusion of low-molecular-weight iron dextran in patients with chronic kidney disease.

Sinha S, Chiu DY, Peebles G, Kolakkat S, Lamerton E, Fenwick S, Kalra PA.

NDT Plus. 2009 Oct;2(5):432-3. doi: 10.1093/ndtplus/sfp073. No abstract available.

7.

The limitations of routine total digoxin immunoassay in patients with advanced chronic kidney disease.

Sharma R, Guy M, Rudenski A, Lamerton E, Kalra PA.

QJM. 2009 Oct;102(10):747-50. doi: 10.1093/qjmed/hcp088. Epub 2009 Jul 14. No abstract available.

PMID:
19602599
8.

Comparison of intravenous iron sucrose versus low-molecular-weight iron dextran in chronic kidney disease.

Sinha S, Chiu DY, Peebles G, Kolakkat S, Lamerton E, Fenwick S, Kalra PA.

J Ren Care. 2009 Jun;35(2):67-73. doi: 10.1111/j.1755-6686.2009.00099.x.

PMID:
19432851
9.

Small bowel angiodysplasia in a patient on haemodialysis: difficulties in diagnosis and management.

Sinha S, Williams JL, Eddington H, Chrysochou C, Lamerton E, Babbs C, Cowie A, Smithard DJ, Kalra PA.

BMJ Case Rep. 2009;2009. pii: bcr07.2008.0542. doi: 10.1136/bcr.07.2008.0542. Epub 2009 Mar 27.

10.

Milk alkali syndrome associated with excessive ingestion of Rennie: case reports.

Irtiza-Ali A, Waldek S, Lamerton E, Pennell A, Kalra PA.

J Ren Care. 2008 Jun;34(2):64-7. doi: 10.1111/j.1755-6686.2008.00018.x. Review.

PMID:
18498570
11.

Serious adverse incidents with the usage of low molecular weight heparins in patients with chronic kidney disease.

Farooq V, Hegarty J, Chandrasekar T, Lamerton EH, Mitra S, Houghton JB, Kalra PA, Waldek S, O'Donoghue DJ, Wood GN.

Am J Kidney Dis. 2004 Mar;43(3):531-7.

PMID:
14981611

Supplemental Content

Loading ...
Support Center